Literature DB >> 28331679

A Rare Entity of Breast Cancer: Primary Neuroendocrin Carcinoma.

Mehmet Abdussamet Bozkurt1, Ali Kocataş1, Yasemin Özkan2, Mustafa Uygar Kalaycı1, Halil Alış1.   

Abstract

Breast cancer is the second leading cause of cancer throughout the world, however neuroendocrine tumors of the breast are rarely encountered. Herein we present a 75-year-old patient who was admitted to our clinic due to a mass in her breast and was operated on with a preliminary diagnosis of invasive breast carcinoma, However she was diagnosed with a neuroendocrine tumor after pathologic evaluation. The patient is the oldest one among others with a neuroendocrine tumor in the breast reported in the literature.

Entities:  

Keywords:  Neuroendocrine tumors; breast cancer; mastectomy

Year:  2014        PMID: 28331679      PMCID: PMC5351523          DOI: 10.5152/tjbh.2014.1768

Source DB:  PubMed          Journal:  J Breast Health        ISSN: 1306-0945


  10 in total

1.  Primary neuroendocrine small cell carcinoma of the breast.

Authors:  B Samli; S Celik; T Evrensel; B Orhan; I Tasdelen
Journal:  Arch Pathol Lab Med       Date:  2000-02       Impact factor: 5.534

Review 2.  Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature.

Authors:  T Adegbola; C E Connolly; G Mortimer
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

3.  Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.

Authors:  M Papotti; L Macrì; G Finzi; C Capella; V Eusebi; G Bussolati
Journal:  Semin Diagn Pathol       Date:  1989-05       Impact factor: 3.464

4.  Neuroendocrine differentiated breast carcinoma: imaging features correlated with clinical and histopathological findings.

Authors:  Isil Günhan-Bilgen; Osman Zekioglu; Esin Emin Ustün; Aysenur Memis; Yildiz Erhan
Journal:  Eur Radiol       Date:  2002-08-14       Impact factor: 5.315

5.  [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics].

Authors:  W Böcker
Journal:  Verh Dtsch Ges Pathol       Date:  2002

6.  Neuroendocrine carcinoma of the breast--diagnostic and clinical implications.

Authors:  Rafal Watrowski; Christoph Jäger; Dominik Mattern; Catherina Horst
Journal:  Anticancer Res       Date:  2012-11       Impact factor: 2.480

7.  Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact?

Authors:  Rupert Prommegger; Christian Ensinger; Philipp Steiner; Tonja Sauper; Christoph Profanter; Raimund Margreiter
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

8.  Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.

Authors:  Eugeni López-Bonet; Miguel Alonso-Ruano; Graciela Barraza; Alejandro Vazquez-Martin; Luis Bernadó; Javier A Menendez
Journal:  Oncol Rep       Date:  2008-12       Impact factor: 3.906

9.  Synchronous solid neuroendocrine breast carcinoma and abdominal lymphoma: A case report and review of the literature.

Authors:  Miguel Alonso-Ruano; Eugeni López-Bonet; Maria Victoria Huerta-Anaya; Ester Vila-Camps; Luis Bernadó; Francesc Tuca-Rodríguez; Pedro Suarez-Pumariega; Javier A Menendez
Journal:  Oncol Lett       Date:  2012-11-23       Impact factor: 2.967

10.  A rare case of primary infiltrating neuroendocrine carcinoma of the breast.

Authors:  Ouzreiah Nawawi; Keat Ying Goh; Kartini Rahmat
Journal:  Iran J Radiol       Date:  2012-11-20       Impact factor: 0.212

  10 in total
  2 in total

1.  A rare breast tumor: primary neuroendocrine carcinoma.

Authors:  Hüseyin Pülat; Mehmet Zafer Sabuncuoğlu; Oktay Karaköse; Mehmet Fatih Benzin; Hasan Erol Eroğlu; Kemal Kürşat Bozkurt Kemal Kürşat Bozkurt
Journal:  Turk J Surg       Date:  2018-01-03

Review 2.  Neuroendocrine breast carcinoma: a rare but challenging entity.

Authors:  Elena Trevisi; Anna La Salvia; Lorenzo Daniele; Maria Pia Brizzi; Giovanni De Rosa; Giorgio V Scagliotti; Massimo Di Maio
Journal:  Med Oncol       Date:  2020-07-25       Impact factor: 3.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.